Latest Headlines

  1. Cytespace Africa Labs Expands Molecular Testing Capacity To Advance Clinical Trials Across Sub-Saharan Africa 1/20/2026

    Cytespace Africa Laboratories (Cytespace), an MLM Medical Labs company and the only fully CAP-accredited central laboratory in South Africa, has significantly expanded its molecular testing capabilities to meet rising demand across Sub-Saharan Africa. 

  2. NeuroQure Launches First-Ever Functional Biophysical Marker Test For Autism, Transforming Early Autism Risk Diagnosis 1/20/2026

    NeuroQure, a pioneering leader in neurological diagnostics, announces the launch of ASD Insight, a first-of-its-kind test designed to identify autism risk as early as birth.

  3. Instrument Manager™ v9.01 Brings New Features And Improved Security To Clinical Laboratories 1/15/2026

    Data Innovations® (DI), the healthcare industry's leading laboratory middleware provider, has released Instrument Manager™ (IM) v9.01.

  4. BD Receives FDA 510(k) Clearance For EnCor EnCompass™ Breast Biopsy And Tissue Removal System 1/15/2026

    BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the EnCor EnCompass™ Breast Biopsy and Tissue Removal System, a state-of-the-art multi-modality breast biopsy system designed to provide clinicians with flexibility across breast imaging modalities in the diagnosis of breast disease.

  5. PHC Corporation Of North America Launches TwinGuard ECO 703VXH Freezer, Bringing New Energy Efficiency To Research Sample Protection 1/15/2026

    PHC Corporation of North America (PHCNA), provider of PHCbi brand sample storage and cell cultivation solutions in North America and Latin America, a subsidiary of PHC Holdings Corporation, has launched its latest innovation in ultra-low temperature (ULT) storage: the TwinGuard ECO 703VXH.

  6. Henry Schein Enters Exclusive Distribution Agreement For CytoChip's CLIA-Waived Hematology Analyzer 1/15/2026

    Henry Schein, Inc has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device.

  7. Affidea Acquires A Majority Stake In LabPoint From Lindenhofgruppe, Strengthening Its Diagnostics And Laboratory Medicine Capabilities 1/14/2026

    Affidea Group, Europe’s leading provider of advanced diagnostics, community-based polyclinics and specialised healthcare services including oncology, announces the acquisition of a majority stake in LabPoint S.A. from Lindenhofgruppe.

  8. CancerIQ Unveils A Risk-Based Early Cancer Detection Program For Imaging & Diagnostics 1/13/2026

    CancerIQ, the leading precision health company focused on cancer early detection, today announced a new risk-based early cancer detection program designed to help diagnostics and imaging companies — and the providers who use their technologies — match the right people to the right screening approaches and get those tests completed at scale.

  9. Labcorp Expands MRD Testing For Breast, Lung And Colon Cancer Recurrence Risk 1/13/2026

    Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the continued expansion of its molecular residual disease (MRD)i portfolio designed to help clinicians detect cancer recurrence earlier than traditional imaging. 

  10. HCAP Partners Announces Follow-On Acquisition For Integrated Diagnostic Services (IDS) With The Addition Of Core Analytics Lab & Radiology 1/13/2026

    HCAP Partners, a California-based private equity firm and nationally recognized impact investor, today announced a follow-on acquisition for its Integrated Diagnostic Services (IDS) platform with the addition of Core Analytics Lab & Radiology (Core), a leading provider of mobile radiology and laboratory services across California.